BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Argus Health
Harvard Business School
Julphar
Queensland Health
Johnson and Johnson
AstraZeneca
Covington
Boehringer Ingelheim

Generated: January 19, 2018

DrugPatentWatch Database Preview

THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Theophylline 0.4% And Dextrose 5% In Plastic Container, and when can generic versions of Theophylline 0.4% And Dextrose 5% In Plastic Container launch?

Theophylline 0.4% And Dextrose 5% In Plastic Container is a drug marketed by B Braun and is included in two NDAs.

The generic ingredient in THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
Pharmacology for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
Ingredient-typeXanthines
Drug ClassMethylxanthine
Medical Subject Heading (MeSH) Categories for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019212-003 Nov 7, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019212-002 Nov 7, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019826-005 Aug 14, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Medtronic
Harvard Business School
Johnson and Johnson
Argus Health
UBS
Queensland Health
Chubb
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot